Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Ovarian Neoplasms × Ultrasonography × Clear all

Status

Unknown 1 Completed 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 5 Liver Neoplasms 3 Thyroid Nodule 2 Polycystic Ovary Syndrome 2 Hypersensitivity 2 Uveal Melanoma 1 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Thoracic Neoplasms 1 Salivary Gland Diseases 1 Rectal Neoplasms 1 Ovarian Neoplasms 1 Ovarian Cysts 1 Oligomenorrhea 1 Menstruation Disturbances 1 Malignant Tumor of Women's Reproductive System 1 Lung Neoplasms 1 Liver Cirrhosis 1 Leiomyoma 1 Intestinal Perforation 1 Hyperandrogenism 1 Hirsutism 1 Head and Neck Neoplasms 1 Enterocolitis, Necrotizing 1 Endometrial Neoplasms 1 Endocrine System Diseases 1 Colonic Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Intraductal, Noninfiltrating 1 Carcinoma, Hepatocellular 1

Interventions

Carboplatin 35 Paclitaxel 34 Bevacizumab 13 olaparib 12 niraparib 11 apatinib 11 Cisplatin 10 liposomal doxorubicin 9 Gemcitabine 9 Cyclophosphamide 8 fludarabine 7 Hyperthermic Intraperitoneal Chemotherapy 7 Etoposide 7 pembrolizumab 6 Topotecan 5 Drug Therapy 5 fluzoparib 4 anlotinib 4 Surveys and Questionnaires 4 Ifosfamide 4 Doxorubicin 4 Docetaxel 4 Albumin-Bound Paclitaxel 4 oregovomab 3 Taxes 3 Poly(ADP-ribose) Polymerase Inhibitors 3 Cytoreduction Surgical Procedures 3 Amplified Fragment Length Polymorphism Analysis 3 1-dodecylpyridoxal 3 pazopanib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03808792 2019-01-18

ISAAC

Charles University, Czech Republic

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡